Ironwood Pharmaceuticals to Attend Jefferies Global Healthcare Conference

7 June 2024

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) had revealed that Sravan Emany, its Chief Financial Officer, would engage in a conversational session at the Jefferies Global Healthcare Conference. This event was scheduled for Thursday, June 6, 2024, at 9:00 a.m. Eastern Time and took place at the Marriott Marquis in New York City.

For those interested in viewing the live session, it was streamed via a webcast accessible through the Investors section of Ironwood’s official website. To ensure seamless access, viewers were advised to log on to the website approximately 15 minutes prior to the session's commencement to accommodate any necessary software updates. Additionally, a recording of the webcast was available on Ironwood's website for a duration of one year following the event.

Ironwood Pharmaceuticals, listed on Nasdaq as IRWD and a member of the S&P SmallCap 600®, is at the forefront of gastrointestinal (GI) healthcare. The company is dedicated to enhancing the treatment landscape for GI diseases and setting new benchmarks for patient care. They are renowned for their development of LINZESS® (linaclotide), a leading prescription medication in the U.S. market for adults suffering from irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). LINZESS is also approved for treating functional constipation in pediatric patients aged 6-17 years.

In addition to LINZESS, Ironwood is making significant strides with apraglutide, a new, long-acting synthetic GLP-2 analog aimed at treating rare GI conditions, including short bowel syndrome with intestinal failure (SBS-IF). The company is also advancing several other early-stage assets. Driven by a legacy of innovation in GI health, Ironwood places patients at the center of their research, development, and marketing efforts to alleviate the burden of GI diseases and address pressing, unmet medical needs.

Founded in 1998, Ironwood Pharmaceuticals operates out of its headquarters in Boston, Massachusetts, with an additional site located in Basel, Switzerland. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!